Treating with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (tkis) accompanying lower incidence of second primary cancers
WR Chou, BC Shia, YC Huang, CW Ho… - Journal of Clinical …, 2022 - mdpi.com
Lung cancer survivors are at risk of developing second primary cancers (SPCs). Although
some risk factors for the development of SPCs have been addressed, their impacts have not …
some risk factors for the development of SPCs have been addressed, their impacts have not …